The Latest Breaking News from Viking

Eli Lilly stock tumbled Thursday on an unexpected setback for its obesity franchise, sending shares of its rival flying.

Viking Mira is getting ready to welcome cruise passengers from spring 2026

With a strong pipeline, these two biotechs are poised for explosive growth.

When you invest in a new appliance, you expect it to last for years. For decades, consumers trusted certain brand names to deliver durability and performance. However, due to corporate mergers, changes in manufacturing, and a focus on cutting costs, many of those once-great brands are no longer a safe…

Viking Holdings (VIK) shows strong technical momentum and hit a new 52-week high on July 15. The stock has a 100% technical “Buy” signal via Barchart. Shares are up more than 60% in the last year. Fundamentals are robust and analyst sentiment is largely bullish on the cruise and expedition...

The river cruise brand is working on a new ship that will sail exclusively in the region

From one Vikings legendary receiver to another.

In a time when so many products are made overseas, it’s refreshing to know some companies are still committed to manufacturing in America. Buying American-made appliance brands not only supports U.S. jobs, but it also often means better quality, easier service, and faster parts replacement. While not every part is…

Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off.